Model examines pregnancy's effects on opioid addiction treatment

pregnancy
Credit: CC0 Public Domain

Buprenorphine (BUP) is approved for the treatment of opioid addiction. The current dosing regimen of BUP in pregnant women is based on recommendations designed for non-pregnant adults, but physiological changes during pregnancy may alter BUP exposure and efficacy.

As described in a British Journal of Clinical Pharmacology study, researchers have developed a physiologically based pharmacokinetic model that predicts changes in BUP exposure at different stages of . The model predicted a decrease in BUP exposure during pregnancy and demonstrated the need for an increase in dose or dosing frequency to maintain efficacy throughout pregnancy. This must be followed by a reduction in dose of after delivery.

"Modeling can help make predictions when it is difficult to get actual data in a patient population such as pregnant women with opiate . Our predictions in fact agree with our clinical observations in a small number of patients published earlier. Lack of recognition of the impact of pregnancy on how the body handles drugs can cause therapeutic failure and may explain the high withdrawal rate of subjects on methadone / buprenorphine maintenance therapy for opioid addiction," said senior author Dr. Raman Venkataramanan, of the University of Pittsburgh School of Pharmacy.


Explore further

Researchers publish study on new therapy to treat opioid use disorder

More information: Hongfei Zhang et al, Gestational Changes in Buprenorphine Exposure: A Physiologically Based Pharmacokinetic Analysis, British Journal of Clinical Pharmacology (2018). DOI: 10.1111/bcp.13642
Provided by Wiley
Citation: Model examines pregnancy's effects on opioid addiction treatment (2018, June 6) retrieved 23 April 2019 from https://medicalxpress.com/news/2018-06-pregnancy-effects-opioid-addiction-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more